These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2975571)

  • 1. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin.
    de Meijer PH; Lutterman JA; van't Laar A
    Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.
    Francis AJ; Hanning I; Alberti KG
    Diabetologia; 1985 Jun; 28(6):330-4. PubMed ID: 3899818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus.
    Van Haeften TW; Bolli GB; Dimitriadis GD; Gottesman IS; Horwitz DL; Gerich JE
    Metabolism; 1986 Jul; 35(7):649-56. PubMed ID: 3523119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variability of the absorption of subcutaneously injected insulin: effect of injection technique and relation with brittleness.
    de Meijer PH; Lutterman JA; van Lier HJ; van't Laar A
    Diabet Med; 1990 Jul; 7(6):499-505. PubMed ID: 2142052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in injection-site blood flow and plasma free insulin concentrations in response to stress in type 1 diabetic patients.
    Greenhalgh PM; Jones JR; Jackson CA; Smith CC; Yudkin JS
    Diabet Med; 1992; 9(1):20-9. PubMed ID: 1551306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma insulin and C-peptide levels during continuous subcutaneous insulin infusion.
    Slama G; Buu KN; Tchobroutsky G; Delage A; Desplanque N
    Diabetes Care; 1979; 2(3):251-5. PubMed ID: 510116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
    Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
    Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exercise on the absorption of insulin glargine in patients with type 1 diabetes.
    Peter R; Luzio SD; Dunseath G; Miles A; Hare B; Backx K; Pauvaday V; Owens DR
    Diabetes Care; 2005 Mar; 28(3):560-5. PubMed ID: 15735188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?
    Kim MR; Sheeler LR; Mansharamani N; Haug MT; Faiman C; Gupta MK
    Endocrine; 1997 Jun; 6(3):285-91. PubMed ID: 9368685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM.
    Frid A; Ostman J; Linde B
    Diabetes Care; 1990 May; 13(5):473-7. PubMed ID: 2190773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absorption kinetics of subcutaneously infused U 40 and U 100 insulin in diabetics.
    Wahab PJ; Rijnsburger AW; van der Veen EA; Heine RJ
    Diabetes Res Clin Pract; 1987; 3(4):203-6. PubMed ID: 3304907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy.
    Porcellati F; Fanelli C; Bottini P; Epifano L; Rambotti AM; Lalli C; Pampanelli S; Scionti L; Santeusanio F; Brunetti P
    Diabetes; 1993 Jul; 42(7):1055-64. PubMed ID: 8513972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.